Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic markerMasashi Takawa, Ryuji Hamamoto, Hyun‐Soo Cho et al.|Cancer Science|2011Cited by 191
Histone Lysine Methyltransferase Wolf-Hirschhorn Syndrome Candidate 1 Is Involved in Human Carcinogenesis through Regulation of the Wnt PathwayGouji Toyokawa, Ryuji Hamamoto, Hyun‐Soo Cho et al.|Neoplasia|2011Cited by 99
The JmjC domain‐containing histone demethylase KDM3A is a positive regulator of the G<sub>1</sub>/S transition in cancer cells <i>via</i> transcriptional regulation of the <i>HOXA1</i> geneHyun‐Soo Cho, Ryuji Hamamoto, Gouji Toyokawa et al.|International Journal of Cancer|2011Cited by 96